Skip to content

Study of Kameshwar rasa in the managment of Anemia.

Randomized controlled clinical trial to study the efficacy of Kameshawar Rasa in the management of kaphaj pandu - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/076907
Enrollment
66
Registered
2024-11-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D649- Anemia, unspecified

Interventions

None listed

Sponsors

Dr Mayur Patil Post Graduate Student at Bhartiya Sanskriti Darshan Trusts Ayurved Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having lakshanas Shwetavbhasata, Akshikutashotha, Hridayaspandan, Shwasa, Gaurava, Bhrama, Klama, Praseka, Aruchi, Alasya. 2. Patients having any 3-4 lakshanas will be enrolled in the study. 3. Patients of any gender will be selected between age group 18 to 60 yrs. 4. Hemoglobin percentage -Female -6-11gm/dl and Male-7-12gm/dl.

Exclusion criteria

Exclusion criteria: 1. Known case of Aplastic Anemia, Sickle cell Anemia. 2. Pregnant women, lactating mothers. 3. Patients with hemorrhagic disorders. 4. Patient with severe systemic disorders and surgical illness.

Design outcomes

Primary

MeasureTime frame
The effect of Kameshwar rasa in the management of Kaphaj Pandu on the basis of haemogram.Timepoint: 15th day and 30th Day

Secondary

MeasureTime frame
To compare the effect of the kameshwar Rasa & Navayas loha vati in the management of Kaphaj Pandu To study the effect of Kameshwar Rasa by complete blood count To observe the adverse effect of Kameshwar Rasa if anyTimepoint: 15th day & 30th Day

Countries

India

Contacts

Public ContactVd Sushrut S Sardeshmukh

Bhartiya Sanskriti Darshan Trusts Ayurved Mahavidyalaya

ayuharmony@gmail.com9011074077

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026